|Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial |
Citybizlist (press release)
... the second patient to receive stem cells in the cervical (upper back) region of the spine was dosed on February 29th in the ongoing Phase I trial of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
See all stories on this topic »
Post a Comment